359 related articles for article (PubMed ID: 37831403)
1. Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus.
Jayasree PJ; Dutta S; Karemore P; Khandelia P
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37831403
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Expression Regulation for RNA m6A Regulators With Clinical Significance in Human Cancers.
Liu X; Wang P; Teng X; Zhang Z; Song S
Front Oncol; 2021; 11():624395. PubMed ID: 33718187
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
[TBL] [Abstract][Full Text] [Related]
4. Research progress of N6-methyladenosine in colorectal cancer: A review.
Lin Y; Shi H; Wu L; Ge L; Ma Z
Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
[TBL] [Abstract][Full Text] [Related]
5. RNA m6A methylation regulators in liver cancer.
Xu Q; Ren N; Ren L; Yang Y; Pan J; Shang H
Cancer Cell Int; 2024 Jan; 24(1):1. PubMed ID: 38166832
[TBL] [Abstract][Full Text] [Related]
6. mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification.
Kumari R; Ranjan P; Suleiman ZG; Goswami SK; Li J; Prasad R; Verma SK
Cardiovasc Res; 2022 Jun; 118(7):1680-1692. PubMed ID: 33956076
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.
Chen Z; Hu Y; Jin L; Yang F; Ding H; Zhang L; Li L; Pan T
Front Pharmacol; 2022; 13():873030. PubMed ID: 35462896
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
Front Oncol; 2022; 12():927640. PubMed ID: 35936737
[TBL] [Abstract][Full Text] [Related]
10. RNA N6-methyladenosine methylation and skin diseases.
Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M
Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146
[TBL] [Abstract][Full Text] [Related]
11. Role of N6-methyladenosine RNA modification in gastric cancer.
Ding SQ; Zhang XP; Pei JP; Bai X; Ma JJ; Zhang CD; Dai DQ
Cell Death Discov; 2023 Jul; 9(1):241. PubMed ID: 37443100
[TBL] [Abstract][Full Text] [Related]
12. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
Fang X; Li M; Yu T; Liu G; Wang J
Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
[TBL] [Abstract][Full Text] [Related]
13. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
[TBL] [Abstract][Full Text] [Related]
14. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
Liao Y; Han P; Zhang Y; Ni B
Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
[TBL] [Abstract][Full Text] [Related]
15. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
16. Effects of writers, erasers and readers within miRNA-related m6A modification in cancers.
Feng H; Yuan X; Wu S; Yuan Y; Cui L; Lin D; Peng X; Liu X; Wang F
Cell Prolif; 2023 Jan; 56(1):e13340. PubMed ID: 36162823
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.
Meng Q; Schatten H; Zhou Q; Chen J
Aging (Albany NY); 2023 Jul; 15(13):6577-6619. PubMed ID: 37437245
[TBL] [Abstract][Full Text] [Related]
18. Emerging function of N6-methyladenosine in cancer.
Hong K
Oncol Lett; 2018 Nov; 16(5):5519-5524. PubMed ID: 30344705
[TBL] [Abstract][Full Text] [Related]
19. The role of m6A modification in the biological functions and diseases.
Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
[TBL] [Abstract][Full Text] [Related]
20. The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.
He C; Teng X; Wang L; Ni M; Zhu L; Liu J; Lv W; Hu J
Mol Biol Rep; 2023 Oct; 50(10):8691-8703. PubMed ID: 37598390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
